Di Zhou, PhD

Principal Scientist
Amgen Inc.

Dr. Di Zhou, PhD, is currently a Principal Scientist at Clinical Pharmacology, Modeling and Simulation (CPMS) department in Amgen. He earned his PhD from the University of Florida in Pharmaceutical Sciences and then joined FDA as a Clinical Pharmacology reviewer at Office of Clinical Pharmacology (OCP). Prior to that, Di also completed a two-year fellowship in Division of Pharmacometrics at FDA OCP.

Poster(s):

• P-211 - CLINICAL PHARMACOLOGY CHARACTERIZATION OF AMG 119, A CHIMERIC ANTIGEN RECEPTOR T (CAR-T) CELL THERAPY TARGETING DELTA-LIKE LIGAND 3 (DLL3), IN PATIENTS WITH RELAPSED/REFRACTORY SMALL CELL LUNG CANCER (R/R SCLC).